From NAFLD to MASLD: When metabolic comorbidity matters

Steatosis Hepatic fibrosis
DOI: 10.1016/j.aohep.2023.101281 Publication Date: 2023-12-21T10:39:19Z
ABSTRACT
In a recent development, cohort of hepatologists has proposed altering the nomenclature non-alcoholic fatty liver disease (NAFLD) to metabolic-associated steatotic (MASLD), accompanied by modified diagnostic criteria. Our objective was investigate effect revised definition on identifying significant hepatic fibrosis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (14)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....